Clinical trial
High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for…
NCT00186394 · Stanford University, Other · Completed
Key facts
| NCT number | NCT00186394 |
|---|---|
| Title | High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's Lymphoma |
| Official title | High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin's Lymphoma |
| Lead sponsor | Stanford University, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma, Non-Hodgkin, Blood and Marrow Transplant (BMT), Lymphomas: Non-Hodgkin |
| Intervention type | Procedure |
| Interventions | ablative allogeneic hematopoietic cell transplantation |
| Enrollment | 35 |
| Start date | Apr 1, 2000 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Jul 27, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: